[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356897-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356897-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","role-of-rna-5-methylcytosine-modification-in-cancer-insights-from-coding-and-non-coding-rnas-review","Role of RNA 5‑methylcytosine modification in cancer: Insights from coding and non‑coding RNAs - Review","","RNA modifications play significant roles in biological processes, with more than 170 modifications identified to date. These chemical changes expand the diversity of RNA species by affecting RNA tertiary structure, biogenesis, subcellular localization and function. High-throughput detection and analytical workflows enable precise mapping of 5‑methylcytosine (m5C). m5C methylation occurs in both coding and non-coding RNAs and is dynamically regulated by writers, erasers and readers. Dysregulated m5C contributes to cancer cell proliferation, migration and drug resistance, supporting targeted posttranscriptional modification therapy. This review summarizes regulatory components and mechanisms driving tumor progression while proposing abnormal m5C as a therapeutic strategy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/role-of-rna-5-methylcytosine-modification-in-cancer-insights-from-coding-and-non-coding-rnas-review/356897/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/role-of-rna-5-methylcytosine-modification-in-cancer-insights-from-coding-and-non-coding-rnas-review/356897.png","ImageObject",300,407,{"name":42,"@type":43},"McQueen","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is RNA 5‑methylcytosine (m5C) and where does it occur?","Question",{"text":63,"@type":64},"m5C is a widespread, evolutionarily conserved RNA modification found in both coding and non-coding RNAs. It is essential for regulating RNA metabolism and function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is m5C modification regulated in cells?",{"text":68,"@type":64},"m5C is dynamically controlled by related enzymes including methyltransferases (writers), demethylases (erasers) and binding proteins (readers). These regulators shape RNA methylation patterns in coding and non-coding RNAs.",{"name":70,"@type":61,"acceptedAnswer":71},"How does abnormal m5C contribute to cancer progression?",{"text":72,"@type":64},"Aberrant m5C modifications are linked to increased proliferation, migration and drug resistance in cancer cells. The review suggests that targeting abnormal posttranscriptional m5C may support more effective cancer therapies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356897,1791207752,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Molecular Medicine rePorTS 34: 199, 2026  \nRole of RNA 5‑methylcytosine modification in cancer: Insights from coding and non‑coding RNAs (Review)  \nQin JianG1* , Yi GonG1* , MiMi ZHai2 , TenGlonG TanG1 and SuSHun liu 1  \n1Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China; 2Nursing Department, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University),  \nChangsha, Hunan 410015, P.R. China  \nReceived April 16, 2025; Accepted December 17, 2025  \nDOI: 10. 3892/mmr.2026.13909  \nAbstract. RNA modifications serve notable roles in various biological processes, with >170 identified modifications . These modifications increase the complexity of RNA species by influencing their tertiary structure, biogenesis, localization and function. The combination of high‑throughput detection technologies and corresponding analytical workflows provides a precise 5‑methylcytosine (m5C) landscape, helping to eluci‑ date its biological functions. The m5C methylation occurs in coding and non‑coding RNAs and is dynamically regulated by related enzymes, including methyltransferases (writers), demethylases (erasers) and binding proteins (readers) . m5cis involved in various physiological functions and regulates the progression of numerous types of tumors. Aberrant m5c RNA modifications contribute to the proliferation, migration and drug resistance of cancer cells, suggesting that targeting aberrant posttranscriptional modifications in cancer cells may hold promise as an efficient therapy for tumors. The present review systematically outlines the regulatory components of m5C modification, emphasizing their dynamic regulatory roles in RNA metabolism and function. The mechanisms by which m5C modification promotes tumor progression through the regulation of cancer cell proliferation, migration and drug resistance are summarized. The present review proposes that targeting abnormal m5C modifications could serve as a novel strategy for cancer treatment, offering new research directions in oncology.  \nCorrespondence to: Dr Sushun Liu, Department of General Surgery, The Second Xiangya Hospital, Central South University, 139 Renmin Road, Changsha, Hunan 410011, P.R. China  \nE‑mail: [surun9566@csu.edu.cn](surun9566@csu.edu.cn)  \n*Contributed equally  \nKey words: RNA modification, 5‑methylcytosine, mRNA, non‑coding RNA, cancer  \nContents  \n1. Introduction  \n2. Writers, erasers and readers for m5C modification  \n3. Methods for detecting m5C modification  \n4. Modification of m5C in mRNA  \n5. Modification of m5C in ncRNAs  \n6. Conclusions  \n1. Introduction  \nAberrant epigenetic modifications serve pivotal roles in the pathogenesis of a wide range of diseases. A key player in this process is methylation, a biochemical modification catalyzed by methyltransferases that add methyl groups to various targets, including DNA, RNA, histones and other proteins. The specificity and outcome of these methylation events are finely regulated by a complex network of proteins known as methyltransferases (writers), demethylases (erasers) and specific binding proteins (readers) (1) . Recent multiomics studies have clarified that DNA and RNA methylation should not be viewed as isolated layers of regulation; integrated anal‑ yses have shown that compared with DNA methylation, RNA methylation often explains a comparable or even larger frac‑ tion of transcriptional variance (2,3). RNA modifications, such as N6‑methyladenosine (m6A), 5‑methylcytosine (m5C) and 7‑methylguanylate (m7G), are crucial for the epigenetic regula‑ tion of gene expression and cellular functions, and markedly impact the development of numerous human diseases (4,5) . Advances in single‑nucleotide resolution sequencing and m5C antibody‑based sequencing technologies have reignited interest in the role of m5C modifications in human diseases (6) .  \nm5C is a widespread, evolutionarily conserved modifica‑ tion present in bo","cbCaijGJK5HdCQOk","https://ap.wps.com/l/cbCaijGJK5HdCQOk","pdf",1782540,13,"English","# Contents\n## 1. Introduction\n## 2. Writers, erasers and readers for m5C modification\n## 3. Methods for detecting m5C modification\n## 4. Modification of m5C in mRNA\n## 5. Modification of m5C in ncRNAs\n## 6. Conclusions","[{\"question\":\"What is RNA 5‑methylcytosine (m5C) and where does it occur?\",\"answer\":\"m5C is a widespread, evolutionarily conserved RNA modification found in both coding and non-coding RNAs. It is essential for regulating RNA metabolism and function.\"},{\"question\":\"How is m5C modification regulated in cells?\",\"answer\":\"m5C is dynamically controlled by related enzymes including methyltransferases (writers), demethylases (erasers) and binding proteins (readers). These regulators shape RNA methylation patterns in coding and non-coding RNAs.\"},{\"question\":\"How does abnormal m5C contribute to cancer progression?\",\"answer\":\"Aberrant m5C modifications are linked to increased proliferation, migration and drug resistance in cancer cells. The review suggests that targeting abnormal posttranscriptional m5C may support more effective cancer therapies.\"}]","Role of RNA 5‑methylcytosine modification in cancer: Insights from coding and non‑coding RNAs - Review | PDF",1790128153,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca2b02427472227c75f4f6716518ace1.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd5ed7c4c105f8f8328333b6f923dd24.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f10e84beb6d4235c838836640433811.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9915759344ce34d3c32e576be8d2ed69.webp",980,1353]